AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT06997679

Effects of Continuous Passive Movements vs Intermittent Compression in Patients With Post ACL Reconstruction Surgery

A study testing Patients receiving CPM and Patients receiving intermittent compression in people with Anterior Cruciate Ligament Injuries, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

ACL Reconstruction Surgery remains a prevalent and debilitating condition, despite invasive and non-invasive approaches aimed at reducing pain and improving function. This study investigates the additional benefits of Continuous Passive Motion (device based exercise) and Intermittent Compression Therapy (device based… Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
Patients receiving CPM and Patients receiving intermittent compression
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 sitePakistan
Study dates
25 Feb 2025to 1 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Diagnosed by Orthopedic Surgeon and patients who have undergone ACL reconstruction surgery
  • Patients who have undergone arthroscopic ACL reconstruction surgery
  • Both male and female
  • Patients who are within 4th week post-operatively
  • Aged between 20-50

Who cannot join

  • Concomitant injuries such as meniscal tears or ligament sprains
  • Patients who have undergone previous knee surgery, including ACL reconstruction
  • Neurological Condition
  • Cardiovascular disease
  • Patients with allergies or sensitivities to the materials used in the CPM or IC devices

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Shalamar Hospital

    Lahore

Other trials in Pakistan

About this study

Official title: Effects of Continuous Passive Movements Versus Intermittent Compression in Patients With Post ACL Reconstruction Surgery

ACL Reconstruction Surgery remains a prevalent and debilitating condition, despite invasive and non-invasive approaches aimed at reducing pain and improving function. This study investigates the additional benefits of Continuous Passive Motion (device based exercise) and Intermittent Compression Therapy (device based program) in individuals with Post ACL Reconstruction Surgery.

Read the detailed description

The researcher employs a randomized controlled trial methodology. Participants are enrolled into two groups: one receiving Continuous Passive Motion (CPM), and the other receiving Intermittent Compression Therapy(IC).

Being tested
Patients receiving CPM, Patients receiving intermittent compression
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients receiving CPMDiagnostic test

    Group A was treated with Continuous Passive Motion for 30-45 minutes for 2 sessions per day for 8 weeks. CPM can be initiated in the immediate post-operative period, typically within 24-48 hours after surgery. Range of motion will be 0-90 degrees of flexion, with a gradual increase in range over time. Speed is 1-2 cycles per minute. Therapist will Monitor patients for pain and discomfort during CPM, and adjust the protocol as needed. Therapist will Monitor patients range of motion and adjust the CPM protocol to ensure optimal progress. Therapist will monitor patients' knee functions and adjusts the CMP protocol to ensure optimal progress

  • Patients receiving intermittent compressionCombination product

    Group B was treated with Intermittent Compression Therapy for 30-45 minutes for 2 sessions (morning and evening) per day for 8 weeks. Therapist stand beside the patient .IC therapy initiated in the immediate post-operative period, typically within 24-48 hours after surgery .Pressure of device between 30-40 mmHg and Cycle time is 10-30 seconds inflation, 10-30 seconds deflation. Therapist will Monitor patients for pain and discomfort during IC therapy, and adjust the protocol as needed. Therapist will Monitor patients' swelling and edema, and adjust the IC therapy protocol to ensure optimal progress. Therapist will Monitor patients' knees functions and adjust the IC therapy protocol to ensure optimal progress.

Study groups in NCT06997679
Study groupRoleWhat they receive
Patients receiving CPMExperimentalNot described
Receives: Diagnostic Test: Patients receiving CPM
Patients receiving intermittent compressionActive comparatorNot described
Receives: Combination Product: Patients receiving intermittent compression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analog scale VAS

    The 10-point numeric scale ranges from '0' representing "no pain" to '10' representing "pain as bad as you can imagine" or "worst pain imaginable".

    Measured: 12 Months

  2. Knee injury and osteoarthritis outcome score KOOS

    The questionnaire has been designed to evaluate Assess the symptoms, function, and quality of life of patients with knee injuries (ACL) or osteoarthritis. There are 5 sections with 42 questions. Each section total score is 100. Each question score between 0-4.Score of 8-10 points is considered clinically significant. Symptoms includes 7 questions which between 0-100. Severe symptoms (0-30), Moderate symptoms (31-60), Mild symptoms (61-100)

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2025
  2. Study start25 Feb 2025
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion1 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06997679
Sponsor's protocol ID
MSRSW/Batch-Fall23/825
Status last verified
May 2025
First submitted
21 May 2025
Last updated
30 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Patients receiving CPM and Patients receiving intermittent compression in people with Anterior Cruciate Ligament Injuries, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 30 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analog scale VAS (time frame: 12 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in